Cargando…
Evidence that a neutrophil–keratinocyte crosstalk is an early target of IL-17A inhibition in psoriasis
The response of psoriasis to antibodies targeting the interleukin (IL)-23/IL-17A pathway suggests a prominent role of T-helper type-17 (Th17) cells in this disease. We examined the clinical and immunological response patterns of 100 subjects with moderate-to-severe psoriasis receiving 3 different in...
Autores principales: | Reich, Kristian, Papp, Kim A, Matheson, Robert T, Tu, John H, Bissonnette, Robert, Bourcier, Marc, Gratton, David, Kunynetz, Rodion A, Poulin, Yves, Rosoph, Les A, Stingl, Georg, Bauer, Wolfgang M, Salter, Janeen M, Falk, Thomas M, Blödorn-Schlicht, Norbert A, Hueber, Wolfgang, Sommer, Ulrike, Schumacher, Martin M, Peters, Thomas, Kriehuber, Ernst, Lee, David M, Wieczorek, Grazyna A, Kolbinger, Frank, Bleul, Conrad C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4676308/ https://www.ncbi.nlm.nih.gov/pubmed/25828362 http://dx.doi.org/10.1111/exd.12710 |
Ejemplares similares
-
Approaches to discontinuing efalizumab: an open-label study of therapies for managing inflammatory recurrence
por: Papp, Kim A, et al.
Publicado: (2006) -
A Randomized, blinded assessor study to Evaluate the efFIcacy and safety of etanercept 50 mg once weekly plus as Needed topical agent vs. Etanercept 50 mg twice weekly in patients with moderate to severe plaque psoriasis (REFINE)
por: Papp, KA, et al.
Publicado: (2015) -
Improvements in patient‐reported outcomes in patients with psoriasis receiving etanercept plus topical therapies: results from REFINE
por: Papp, K.A., et al.
Publicado: (2015) -
A Prognostic Gene Signature Expressed in Primary Cutaneous Melanoma: Synergism With Conventional Staging
por: Brunner, Georg, et al.
Publicado: (2018) -
Summer Camp Health Initiative: An Overview of Injury and Illness in Two Canadian Summer Camps
por: Handler, Adam, et al.
Publicado: (2018)